Evidence map›Paper›PMID 36262035›Full record

ArticleCancer2022

Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.

Danielle D Durham, Linn A Abraham, Megan C Roberts, Carly P Khan, Robert A Smith, Karla Kerlikowske, Diana L Miglioretti

Open access · greenAbstract readCase Reports
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Danielle D DurhamDepartment of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-8871-589X
Linn A AbrahamKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.
Megan C RobertsDivision of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.ORCID 0000-0003-3434-2773
Carly P KhanPatient-Centered Outcomes Research Institute, Washington, District of Columbia, USA.
Robert A SmithCancer Control Department, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0003-3344-2238
Karla KerlikowskeDepartment of Medicine, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0001-8793-8779
Diana L MigliorettiKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.ORCID 0000-0002-5547-1833
Kaiser Permanente Washington Health Research Institute · USUniversity of North Carolina at Chapel Hill · USAmerican Cancer Society · USPatient-Centered Outcomes Research Institute · USUniversity of California, San Francisco · US

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
NCI NIH HHS P01 CA154292NCI NIH HHS U54 CA163303
6 · The paper itself

Abstract

backgroundWomen with a first-degree family history of breast cancer are often advised to begin screening when they are 10 years younger than the age at which their relative was diagnosed. Evidence is lacking to determine how much earlier they should begin.

methodsUsing Breast Cancer Surveillance Consortium data on screening mammograms from 1996 to 2016, the authors constructed a cohort of 306,147 women 30-59 years of age with information on first-degree family history of breast cancer and relative's age at diagnosis. The authors compared cumulative 5-year breast cancer incidence among women with and without a first-degree family history of breast by relative's age at diagnosis and by screening age.

resultsAmong 306,147 women included in the study, approximately 11% reported a first-degree family history of breast cancer with 3885 breast cancer cases identified. Women reporting a relative diagnosed between 40 and 49 years and undergoing screening between ages 30 and 39 or 40 and 49 had similar 5-year cumulative incidences of breast cancer (respectively, 18.6/1000; 95% confidence interval [CI], 12.1, 25.7; 18.4/1000; 95% CI, 13.7, 23.5) as women without a family history undergoing screening between 50-59 years of age (18.0/1000; 95% CI, 17.0, 19.1). For relative's diagnosis age from 35 to 45 years of age, initiating screening 5-8 years before diagnosis age resulted in a 5-year cumulative incidence of breast cancer of 15.2/1000, that of an average 50-year-old woman.

conclusionWomen with a relative diagnosed at or before age 45 may wish to consider, in consultation with their provider, initiating screening 5-8 years earlier than their relative's diagnosis age.

Indexed as

Breast NeoplasmsAdultEarly Detection of CancerFemaleHumansIncidenceMammographyMass ScreeningMedical History TakingMiddle AgedRisk FactorsBCSCbreast cancer screeningBreast Cancer Surveillance Consortiumfamily history of breast cancermammography

Identifiers

PMID36262035
PMCPMC9712500
OpenAlexW4306913568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.